Organization
Nektar Therapeutics
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Nektar Therapeutics
... her instructions on breathing as you perform the following exercises. Pilates Breath: Inhale: stretch the ribcages wide, filling up the lungs from the bottom to ...
... Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard Robin, is scheduled to ...
... to the investment community. Today we are offering reports on GRFS, ADXS, NKTR, and ONCE which can be accessed for free by signing up tohttp://www.wallstequities.com/registration. ...
... Nektar Therapeutics, a San Francisco biopharmaceutical company whose pipeline includes a less-addictive opioid ...
... to fight cancer. The Committee has added Idera Pharmaceuticals (Nasdaq: IDRA), Nektar Therapeutics (Nasdaq: NKTR) and Pieris Pharmaceuticals (Nasdaq: PIRS) to the index. These additions ...
... sink deeper into the pose. 1. Begin in downward facing dog pose. Inhale and lift your left leg up. Exhale and move your foot forward, ...
... and shareholders of Hertz Global Holdings, Inc (NYSE:HTZ), Cinedigm Corp (NASDAQ:CIDM), Nektar Therapeutics (NASDAQ:NKTR), Akorn, Inc. (NASDAQ:AKRX), Autodesk, Inc. (NASDAQ:ADSK), and NextEra Energy Partners, LP ...
... wholly owned subsidiary, Precigen. Release > Trying to boost its immuno-oncology pipeline, Nektar Therapeutics made several promotions: Stephen Doberstein, Ph.D., to SVP of R&D and ...
... WallStEquities.com has issued free tailored Stock Review on FGEN, GBT, ICPT, and NKTR which is a click away athttp://www.wallstequities.com/registration. WallStEquities.com is currently focused on the ...
... Nektar Therapeutics (Nasdaq: NKTR) announced today that its corporate presentation will be webcast ...
... financial news website Calcalist. The drugmaker employs nearly 6,900 workers in Israel. Nektar Therapeutics – An experimental pneumonia treatment developed by Nektar and partner Bayer ...
... Bayer today announced that INHALE, a global Phase III clinical study program investigating Amikacin Inhale in addition ...
... Nektar Therapeutics (Nasdaq: NKTR) announced today several promotions on its executive leadership team: Stephen ...
... today announced preclinical data of its neoantigen-based cancer vaccine in combination with Nektar Therapeutics' NKTR-214, a CD122-biased cytokine agonist which is currently in clinical trials. ...
... Nektar Therapeutics (Nasdaq: NKTR) announced today that its corporate presentation will be webcast at ...
... Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the third quarter ended ...
... Nektar Therapeutics (Nasdaq: NKTR) today announced that new clinical data will be presented for ...
... Nektar Therapeutics (Nasdaq: NKTR) today announced it is presenting preclinical data on NKTR-358, a ...
... Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended ...
... If you want a Stock Review on NKTR, OPHT, PTCT, or ONCE then come over tohttp://dailystocktracker.com/register/and sign up for your ...
Want to see the full history on Nektar Therapeutics? Upgrade to RelSci Pro now!
Start My Free Trial